Using a special dye to see head and neck cancer during surgery
Treatments studied
Part of Cancer clinical trials.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have head and neck cancer (or your doctor strongly suspects it) and are planning surgery to remove it.
- You are at least 18 years old.
- If you can become pregnant, you must have a negative pregnancy test before surgery and use birth control for at least 1 week after.
- You are not allergic to ICG, sodium iodide, or similar compounds.
- You have not had a thyroid scan within the past week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dye (ICG) injected before surgery can help surgeons see head and neck cancer more clearly during the operation. It is for people with squamous cell carcinoma who are at risk of their cancer returning and are scheduled for surgery.
This Phase 2 study tests a special camera and dye during surgery to help surgeons confirm they removed all cancer at the edge of the removed tissue. If it works, it may lower the chance of cancer being left behind after oral cavity or oropharynx squamous cell cancer surgery.
This study compares a special imaging dye (indocyanine green) that helps surgeons see blood flow in reconstructed tissue during head and neck surgery. The goal is to see if using this dye helps surgeons make better decisions about whether the reconstructed tissue will survive and heal properly.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.